tradingkey.logo
tradingkey.logo
검색

Immunoprecise Antibodies Ltd

IPA
관심 목록에 추가
2.070USD
0.0000.00%
종가 07/02, 13:00ET시세는 15분 지연됩니다
95.54M시가총액
손실P/E TTM

Immunoprecise Antibodies Ltd

2.070
0.0000.00%

자세한 내용은 Immunoprecise Antibodies Ltd 회사

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

Immunoprecise Antibodies Ltd 정보

종목 코드 IPA
회사 이름Immunoprecise Antibodies Ltd
상장일Jan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
직원 수- -
유형Ordinary Share
회계 연도 종료Jan 30
주소Industrious 823 Congress Ave Suite 300
도시AUSTIN
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호78701
전화16048060626
웹사이트https://www.ipatherapeutics.com/
종목 코드 IPA
상장일Jan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.

Immunoprecise Antibodies Ltd의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shuji Sato
Dr. Shuji Sato
Vice President - Innovative Solutions
Vice President - Innovative Solutions
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--

자주 묻는 질문

Immunoprecise Antibodies Ltd의 상위 5대 주주는 누구인가요?

Immunoprecise Antibodies Ltd의 상위 5대 주주는 다음과 같습니다: Dr. Jennifer Lynne Bath, Ph.D.

Immunoprecise Antibodies Ltd(IPA)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Immunoprecise Antibodies Ltd의 주식을 보유한 기관은 총 47곳이며, 이들이 보유한 주식의 총 가치는 약 4.54M로 전체 발행 주식의 9.73%를 차지합니다. 이는 2025Q4 대비 212280.00 증가한 수치입니다.

Immunoprecise Antibodies Ltd의 최대 수익원은 무엇인가요?

2026Q1 기준, Immunoprecise Antibodies Ltd의 Project revenue 부문이 가장 높은 매출을 기록했으며, 금액은 4.11M로 전체 매출의 98.85%를 차지했습니다.